Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Pharmaceutical Approaches in Dementia
Masaru Tanaka, Nóra Török, László Vécsei
Springer eBooks (2021), pp. 1-18
Closed Access | Times Cited: 19

Showing 19 citing articles:

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
Masaru Tanaka, Fanni Tóth, Helga Polyák, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 734-734
Open Access | Times Cited: 176
Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer’s Disease Pathology and Improve Cognitive Deficits
Yi‐An Chen, Cheng-Hsiu Lu, Chien‐Chih Ke, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 594-594
Open Access | Times Cited: 111
Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
Masaru Tanaka, Fanni Tóth, Helga Polyák, et al.
(2021)
Open Access | Times Cited: 93
Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway
Masaru Tanaka, Nóra Török, Fanni Tóth, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 897-897
Open Access | Times Cited: 72
Monitoring the kynurenine system: Concentrations, ratios or what else?
Masaru Tanaka, László Vécsei
Advances in Clinical and Experimental Medicine (2021) Vol. 30, Iss. 8, pp. 775-778
Open Access | Times Cited: 59
Memory Enhancement with Kynurenic Acid and its Mechanisms in Neurotransmission
Diána Martos, Bernadett Tuka, Masaru Tanaka, et al.
(2022)
Open Access | Times Cited: 37
Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase 1 Influenced the Age Onset of Parkinson's Disease
Nóra Török, Rita Maszlag-Török, Kinga Molnár, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 9
Open Access | Times Cited: 35
Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway
Masaru Tanaka, Nóra Török, Fanni Tóth, et al.
(2021)
Open Access | Times Cited: 31
Therapeutic Potential of Human Stem Cell Implantation in Alzheimer’s Disease
Hau Jun Chan, Yanshree, Jaydeep Roy, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10151-10151
Open Access | Times Cited: 27
The Monkey Head Mushroom and Memory Enhancement in Alzheimer’s Disease
Yanshree, Wing Shan Yu, Man Lung Fung, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2284-2284
Open Access | Times Cited: 20
Implantable trilayer microneedle transdermal delivery system to enhance bioavailability and brain delivery of rivastigmine for Alzheimer treatment: A proof-of-concept study
Nur Rezky Aulia Ilyas, Aprilia Paramitha Dwi Putri, Febriansyah Anandha Pratama, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 201, pp. 114382-114382
Open Access | Times Cited: 4
Redefining Roles: A Paradigm Shift in Tryptophan–Kynurenine Metabolism for Innovative Clinical Applications
Masaru Tanaka, Ágnes Szabó, László Vécsei
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12767-12767
Open Access | Times Cited: 3
Analyzing of Alzheimer’s Disease Based on Biomedical and Socio-Economic Approach Using Molecular Communication, Artificial Neural Network, and Random Forest Models
Yüksel Bayraktar, Esme Işık, İbrahim Işık, et al.
Sustainability (2022) Vol. 14, Iss. 13, pp. 7901-7901
Open Access | Times Cited: 14
Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer’s Disease
Marta Pérez-González, Sara Badesso, Elena Lorenzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9120-9120
Open Access | Times Cited: 18
Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapy for Alzheimer’s Disease: Progress and Opportunity
Yi‐An Chen, Cheng-Hsiu Lu, Chien‐Chih Ke, et al.
Membranes (2021) Vol. 11, Iss. 10, pp. 796-796
Open Access | Times Cited: 17
Protective role of BDNF in Alzheimer’s disease pathophysiology and its correlation with new biomarkers: Can the role of BDNF be re-discussed?
Veysel Tahiroğlu, Elif Uğur, Erkam COŞKUN, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 33, Iss. 8, pp. 773-779
Open Access | Times Cited: 3
Dementia and neurodegenerative disorder: An introduction
Swapnali Vasant Birajdar, Manisha Mulchandani, Farhan Mazahir, et al.
Elsevier eBooks (2022), pp. 1-36
Closed Access | Times Cited: 3
Online Psychoeducational Programmes and Multicomponent Exercise for the Patients with Mild Dementia and their Caregivers: A Systematic Review
Dimitriou TD
Journal of Clinical Case Studies Reviews & Reports (2024) Vol. 6, Iss. 1, pp. 1-6
Open Access
Unraveling the Neurobiological Roots of Despair: Insights from Novel Kynurenine Aminotransferase II Knockout Mice
Ágnes Szabó, Eleonóra Spekker, Mónika Szűcs, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top